Bi-layered living cellular construct resulted in greater healing in an alloxan-induced diabetic porcine model

被引:3
作者
Avery, Justin T. [1 ]
Qiao, Jizeng [2 ]
Medeiros, Erika [3 ]
Bollenbach, Thomas J. [4 ]
Kimmerling, Kelly A. [1 ]
Mowry, Katie C. [1 ]
机构
[1] Organogenesis Inc, Dept Res & Dev, Canton, MA 02021 USA
[2] Editas Med, Cambridge, MA USA
[3] Organogenesis Inc, Dept Qual Control, Canton, MA USA
[4] Adv Regenerat Mfg Inst, Manchester, NH USA
关键词
allogenic; BLCC; diabetes; re-epithelialisation; wound care; VENOUS LEG ULCERS; SKIN-EQUIVALENT; BIOENGINEERED SKIN; DERMAL EQUIVALENT; TISSUE; REPAIR; APLIGRAF(R); MECHANISMS; SURVIVAL; WOUNDS;
D O I
10.1111/iwj.13889
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Tissue-engineered skin constructs, including bi-layered living cellular constructs (BLCC) used in the treatment of chronic wounds, are structurally/functionally complex. While some work has been performed to understand their mechanisms, the totality of how BLCC may function in wound healing remains unknown. To this end, we have developed a delayed wound healing model to test BLCC cellular and molecular mechanisms of action. Diabetes was chemically-induced using alloxan in Yucatan miniature pigs, and full-thickness wounds were generated on their dorsum. These wounds were either allowed to heal by secondary intention alone (control) or treated with a single or multiple treatments of a porcine autologous BLCC. Results indicated a single treatment with porcine BLCC resulted in statistically significant wound healing at day 17, while four treatments resulted in statistically significant healing on days 10, 13, and 17 compared to control. Statistically accelerated wound closure was driven by re-epithelialisation rather than contraction or granulation. This porcine diabetic model and the use of a porcine BLCC allowed evaluation of healing responses in vivo without the complications typically seen with either xenogenic responses of human/animal systems or the use of immune compromised animals, expanding the knowledge base around how BLCC may impact chronic wounds.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 41 条
[1]   Skin Wound Healing: Normal Macrophage Function and Macrophage Dysfunction in Diabetic Wounds [J].
Aitcheson, Savannah M. ;
Frentiu, Francesca D. ;
Hurn, Sheree E. ;
Edwards, Katie ;
Murray, Rachael Z. .
MOLECULES, 2021, 26 (16)
[2]  
Ananta M, 2012, TISSUE ENG PT A, V18, P353, DOI [10.1089/ten.TEA.2011.0208, 10.1089/ten.tea.2011.0208]
[3]   LIVING TISSUE FORMED INVITRO AND ACCEPTED AS SKIN-EQUIVALENT TISSUE OF FULL THICKNESS [J].
BELL, E ;
EHRLICH, HP ;
BUTTLE, DJ ;
NAKATSUJI, T .
SCIENCE, 1981, 211 (4486) :1052-1054
[4]   THE LIVING SKIN EQUIVALENT - ITS MANUFACTURE, ITS ORGANOTYPIC PROPERTIES AND ITS RESPONSES TO IRRITANTS [J].
BELL, E ;
PARENTEAU, N ;
GAY, R ;
NOLTE, C ;
KEMP, P ;
BILBO, P ;
EKSTEIN, B ;
JOHNSON, E .
TOXICOLOGY IN VITRO, 1991, 5 (5-6) :591-596
[5]   SURVIVAL OF CULTURED ALLOGENEIC KERATINOCYTES TRANSPLANTED TO DEEP DERMAL BED ASSESSED WITH PROBE SPECIFIC FOR Y-CHROMOSOME [J].
BRAIN, A ;
PURKIS, P ;
COATES, P ;
HACKETT, M ;
NAVSARIA, H ;
LEIGH, I .
BRITISH MEDICAL JOURNAL, 1989, 298 (6678) :917-919
[6]   Cellular and molecular basis of wound healing in diabetes [J].
Brem, Harold ;
Tomic-Canic, Marjana .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) :1219-1222
[7]   SURVIVAL OF CULTURED ALLOGRAFTS IN PATIENTS WITH BURNS ASSESSED WITH PROBE SPECIFIC FOR Y-CHROMOSOME [J].
BURT, AM ;
PALLETT, CD ;
SLOANE, JP ;
OHARE, MJ ;
SCHAFLER, KF ;
YARDENI, P ;
ELDAD, A ;
CLARKE, JA ;
GUSTERSON, BA .
BRITISH MEDICAL JOURNAL, 1989, 298 (6678) :915-917
[9]   Bioengineered Self-assembled Skin as an Alternative to Skin Grafts [J].
Climov, Mihail ;
Medeiros, Erika ;
Farkash, Evan A. ;
Qiao, Jizeng ;
Rousseau, Cecile F. ;
Dong, Shumin ;
Zawadzka, Agatha ;
Racki, Waldemar J. ;
Al-Musa, Ahmad ;
Sachs, David H. ;
Randolph, Mark A. ;
Huang, Christene A. ;
Bollenbach, Thomas J. .
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2016, 4 (06)
[10]   Bilayered bioengineered skin substitute (Apligraf®) -: A review of its use in the treatment of venous leg ulcers and diabetic foot ulcers [J].
Curran, MP ;
Plosker, GL .
BIODRUGS, 2002, 16 (06) :439-455